Timing is Everything: Defining ADaM Period, Subperiod and Phase chrome-extension://ibllepbpahcoppkjjllbabhnigcbffpi/https://www.lexjansen.com/pharmasug/2019/DS/PharmaSUG-2019-DS-250.pdf

An Introduction to Visit Window Challenges and Solutions chrome-extension://ibllepbpahcoppkjjllbabhnigcbffpi/https://www.lexjansen.com/sesug/2017/CC-125.pdf

ADINTDT and ADTTE for Survival Sweep in Oncology Studies chrome-extension://ibllepbpahcoppkjjllbabhnigcbffpi/https://www.lexjansen.com/pharmasug/2019/DS/PharmaSUG-2019-DS-250.pdf

Efficacy ADaMs in Oncology –Step by Step (Dataset by Dataset) chrome-extension://ibllepbpahcoppkjjllbabhnigcbffpi/https://www.lexjansen.com/phuse-us/2020/si/SI07.pdf

Multiple Imputation Analysisfor Clinical Trials chrome-extension://ibllepbpahcoppkjjllbabhnigcbffpi/https://www.lexjansen.com/pharmasug/2019/ST/PharmaSUG-2019-ST-160.pdf

ADaM Example for a ComplexEfficacy Analysis Dataset chrome-extension://ibllepbpahcoppkjjllbabhnigcbffpi/https://www.pharmasug.org/proceedings/2015/DS/PharmaSUG-2015-DS09.pdf

...